Carty S E, Norton J A
Surgical Metabolism Section, National Cancer Institute, Bethesda, Maryland 20892.
World J Surg. 1991 Nov-Dec;15(6):716-23. doi: 10.1007/BF01665305.
The surgical management of patients with persistent or recurrent primary hyperparathyroidism is reviewed. The several factors allowing the surgeon to formulate a correct working diagnosis and to successfully remove all abnormal parathyroid tissue are individually discussed and recent results of re-operative parathyroid surgery are presented. In particular, direct surgical exploration based on aggressive pre-operative localization studies, the use of intra-operative ultrasound to facilitate intra-operative dissection, cryopreservation of excised parathyroid tissue with potential for delayed autograft to avoid permanent hypoparathyroidism, and the use of intra-operative monitoring of urinary cyclic adenosine monophosphate levels in patients with parathyroid hyperplasia in whom the surgeon is uncertain whether all abnormal parathyroid tissue has been removed, each contribute to a high rate of successful management (greater than 95%) for patients with the difficult problem of persistent or recurrent primary hyperparathyroidism.
本文综述了持续性或复发性原发性甲状旁腺功能亢进患者的手术治疗。分别讨论了使外科医生能够做出正确的工作诊断并成功切除所有异常甲状旁腺组织的几个因素,并介绍了再次手术甲状旁腺手术的近期结果。特别是基于积极的术前定位研究进行直接手术探查,术中使用超声辅助术中解剖,对切除的甲状旁腺组织进行冷冻保存以便可能进行延迟自体移植以避免永久性甲状旁腺功能减退,以及对于甲状旁腺增生且外科医生不确定是否已切除所有异常甲状旁腺组织的患者术中监测尿环磷酸腺苷水平,这些措施均有助于使持续性或复发性原发性甲状旁腺功能亢进这一难题患者获得较高的成功治疗率(超过95%)。